Drugs / Holour
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05093166 | Nov 2021 → Dec 2022 | hypospadias | Holostem s.r.l. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Holour | “Holour is intended for urethral replacement and is made from ex vivo expanded autologous oral mucosal cells including stem cells.” NCT05093166 ↗ |
| Modality | Cell therapy | “Up to 8 patients will be treated by means of autologous cultured oral mucosa grafts containing oral mucosa stem cells.” NCT05093166 ↗ |
| Route | Other | “First stage: application of holour on the wound bed prepared according to standard surgery” NCT05093166 ↗ |